Axsome (AXSM) director sells shares to cover RSU tax obligations
Rhea-AI Filing Summary
Axsome Therapeutics director Roger Jeffs sold 572 shares of common stock in two open-market transactions at prices of $246.18 and $249.12 per share. The sales were executed under a pre-approved Rule 10b5-1 trading plan and to cover taxes on the settlement of previously granted RSUs. After these transactions, he directly holds 58,367 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 572 shares ($141,656)
Net Sell
2 txns
Insider
JEFFS ROGER
Role
Director
Sold
572 shs ($142K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 286 | $249.12 | $71K |
| Sale | Common Stock | 286 | $246.18 | $70K |
Holdings After Transaction:
Common Stock — 58,367 shares (Direct)
Footnotes (1)
- Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed. These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025.
Key Figures
Shares sold on first day: 286 shares
Shares sold on second day: 286 shares
Total shares sold: 572 shares
+1 more
4 metrics
Shares sold on first day
286 shares
Open-market sale at $246.18 per share
Shares sold on second day
286 shares
Open-market sale at $249.12 per share
Total shares sold
572 shares
Two open-market sales in June 2026
Shares held after transactions
58,367 shares
Direct ownership after June 2026 sales
Key Terms
Rule 10b5-1 plan, RSUs, open-market sale
3 terms
Rule 10b5-1 plan regulatory
"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
RSUs financial
"These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
open-market sale financial
"transaction_action: open-market sale; transaction_code_description: Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Axsome Therapeutics (AXSM) director Roger Jeffs report in this Form 4?
Roger Jeffs reported selling 572 Axsome Therapeutics shares in two open-market transactions. The sales occurred at prices between $246.18 and $249.12 per share and were linked to tax obligations from previously granted RSUs under a pre-approved Rule 10b5-1 plan.
What is a Rule 10b5-1 plan as referenced in the Axsome (AXSM) Form 4?
A Rule 10b5-1 plan is a pre-arranged trading plan that allows insiders to sell shares on a set schedule. The filing notes Jeffs’ sales were under such a pre-approved plan, which has now been completed, helping separate these trades from discretionary timing decisions.